How Decentralized Clinical Trial Methods Can Be Leveraged To Overcome Five Common Challenges In Clinical Trials

As anyone involved in clinical trials knows, the process to develop a new medicine is long and expensive, and many drug trials fail. It takes an average of 10 years to bring a drug from discovery to market, with the clinical trials phase taking an average of six to seven years¹. The median cost of a clinical trial to support FDA approval of a new drug is $19 million², and of all drugs in clinical trials, only 14% receive FDA approval³.

With so much at stake for patients and sponsors, research organizations involved in drug development must do all they can to overcome the challenges in clinical trials and increase the likelihood of success. Decentralized clinical trial (DCT) methods can help.

Five common challenges in clinical trials include controlling costs; getting FDA approval; recruiting participants; retaining participants; and completing the trial on time. Learn more on each challenge and how DCT can help overcome them.